跳到主要內容

Cozadd Bruce C 的 Form 4 申報

Jazz Pharmaceuticals plc(JAZZ),2021/11/3 申報

申報編號
0001765581-21-000122
申報時間
2021/11/3
交易日
2021/11/1
申報延遲
2 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 4 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $88.3 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Cozadd Bruce CCIK 0001193210董事、高階主管(董事長、執行長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2021/11/1Ordinary SharesM行使選擇權取得+9,700$46.83+$454,251322,092直接
2021/11/1Ordinary SharesS賣出處分−1,893$133.70F3−$253,094.1320,199直接
2021/11/1Ordinary SharesS賣出處分−1,934$134.78F4−$260,664.52318,265直接
2021/11/1Ordinary SharesS賣出處分−2,729$135.45F5−$369,643.05315,536直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2021/11/1Ordinary SharesM行使選擇權處分−9,700$0.00$087,232直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F3

Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $133.08 to $134.03. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

表 I 有 1 筆交易的價格引用這則附註。

F4

Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $134.163 to $135.134. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

表 I 有 1 筆交易的價格引用這則附註。

F5

Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $135.181 to $135.94. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)